Baidu
map

仅仅两周!美国首例子宫移植女性摘除植入的子宫

2016-04-09 Mechront 译 MedSci原创

2016年2月24日美国克利夫兰诊所的医生对一名26岁的女性进行了子宫移植手术。2周后,因为女性生殖系统常见微生物感染(细菌引起的阴道酵母菌感染),且子宫血供受累,不得不于3月9日切除移植的子宫。两次手术的间隔仅仅2周时间。因为供体的阴道组织也会参与到手术中,所以当前不知道感染是来自供体还是受体。进行子宫移植的供体女性是一名突然死亡的30来岁女性,受体女性名叫Lindsey McFarland,她

2016年2月24日美国克利夫兰诊所的医生对一名26岁的女性进行了子宫移植手术。2周后,因为女性生殖系统常见微生物感染(细菌引起的阴道酵母菌感染),且子宫血供受累,不得不于3月9日切除移植的子宫。两次手术的间隔仅仅2周时间。因为供体的阴道组织也会参与到手术中,所以当前不知道感染是来自供体还是受体。

进行子宫移植的供体女性是一名突然死亡的30来岁女性,受体女性名叫Lindsey McFarland,她与老公已经收养了3个小孩,但是一直渴望生下自己的孩子。Lindsey在3月发布的一份声明中说,很不幸,子宫移植的梦想又退回到原地。

她说:“我只是想花一点时间来表达我对所有医生的谢意。为确保我的健康和安全,医生们行动很快。虽然我不幸的失去了子宫,不过我很好,感谢所有为我祈祷和好心的人们。”

The New York Times报道说,克利夫兰诊所的医生计划对该手术进行更多的研究,以避免将来出现类似问题。正在考虑的措施包括预防使用抗真菌药物、对供体和受体组织进行洗涤来减少感染的风险。

医生说,他们正在限制移植到体内的子宫的残留,因为妇女必须服用强有力的药物,以防止身体对移植子宫的抗拒,他们不希望移植子宫的女性一辈子都要靠药物来让身体接纳移植的子宫。

这是美国进行的第一例子宫移植,该技术率先在瑞典开展,截至去年9月,已经完成了9例子宫移植,并达到了5次妊娠,产下4名宝宝。此外,移植子宫产下的宝宝都做得很好。

原始出处:

Common infection caused first US uterus transplant to fail, hospital says.MedicalXpress.April 8, 2016 by Steven Reinberg, Healthday Reporter

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1645896, encodeId=90b41645896c2, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Thu Feb 23 22:59:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78134, encodeId=fdcee813456, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78135, encodeId=e829e813513, content=会好的会好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520304, encodeId=a1791520304c0, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Mon Apr 11 01:59:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76639, encodeId=b365e663922, content=愿技术不断完善, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Sun Apr 10 07:28:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76625, encodeId=9a82e66256c, content=可惜了,愿该项技术越来越成熟,惠及人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00531550470, createdName=layyjiangli, createdTime=Sat Apr 09 20:24:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76586, encodeId=093ce6586c4, content=随缘, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sat Apr 09 13:20:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76580, encodeId=7525e658051, content=看来3D打印器官时代快来了,永生梦想也开始起步了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sat Apr 09 12:30:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76578, encodeId=faa8e6578d4, content=子宫移植,还得抗排斥治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Sat Apr 09 12:11:00 CST 2016, time=2016-04-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1645896, encodeId=90b41645896c2, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Thu Feb 23 22:59:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78134, encodeId=fdcee813456, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78135, encodeId=e829e813513, content=会好的会好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520304, encodeId=a1791520304c0, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Mon Apr 11 01:59:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76639, encodeId=b365e663922, content=愿技术不断完善, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Sun Apr 10 07:28:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76625, encodeId=9a82e66256c, content=可惜了,愿该项技术越来越成熟,惠及人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00531550470, createdName=layyjiangli, createdTime=Sat Apr 09 20:24:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76586, encodeId=093ce6586c4, content=随缘, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sat Apr 09 13:20:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76580, encodeId=7525e658051, content=看来3D打印器官时代快来了,永生梦想也开始起步了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sat Apr 09 12:30:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76578, encodeId=faa8e6578d4, content=子宫移植,还得抗排斥治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Sat Apr 09 12:11:00 CST 2016, time=2016-04-09, status=1, ipAttribution=)]
    2016-04-14 李继凯

    继续关注

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1645896, encodeId=90b41645896c2, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Thu Feb 23 22:59:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78134, encodeId=fdcee813456, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78135, encodeId=e829e813513, content=会好的会好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520304, encodeId=a1791520304c0, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Mon Apr 11 01:59:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76639, encodeId=b365e663922, content=愿技术不断完善, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Sun Apr 10 07:28:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76625, encodeId=9a82e66256c, content=可惜了,愿该项技术越来越成熟,惠及人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00531550470, createdName=layyjiangli, createdTime=Sat Apr 09 20:24:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76586, encodeId=093ce6586c4, content=随缘, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sat Apr 09 13:20:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76580, encodeId=7525e658051, content=看来3D打印器官时代快来了,永生梦想也开始起步了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sat Apr 09 12:30:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76578, encodeId=faa8e6578d4, content=子宫移植,还得抗排斥治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Sat Apr 09 12:11:00 CST 2016, time=2016-04-09, status=1, ipAttribution=)]
    2016-04-14 李继凯

    会好的会好的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1645896, encodeId=90b41645896c2, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Thu Feb 23 22:59:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78134, encodeId=fdcee813456, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78135, encodeId=e829e813513, content=会好的会好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520304, encodeId=a1791520304c0, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Mon Apr 11 01:59:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76639, encodeId=b365e663922, content=愿技术不断完善, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Sun Apr 10 07:28:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76625, encodeId=9a82e66256c, content=可惜了,愿该项技术越来越成熟,惠及人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00531550470, createdName=layyjiangli, createdTime=Sat Apr 09 20:24:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76586, encodeId=093ce6586c4, content=随缘, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sat Apr 09 13:20:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76580, encodeId=7525e658051, content=看来3D打印器官时代快来了,永生梦想也开始起步了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sat Apr 09 12:30:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76578, encodeId=faa8e6578d4, content=子宫移植,还得抗排斥治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Sat Apr 09 12:11:00 CST 2016, time=2016-04-09, status=1, ipAttribution=)]
    2016-04-11 jiyangfei
  5. [GetPortalCommentsPageByObjectIdResponse(id=1645896, encodeId=90b41645896c2, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Thu Feb 23 22:59:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78134, encodeId=fdcee813456, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78135, encodeId=e829e813513, content=会好的会好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520304, encodeId=a1791520304c0, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Mon Apr 11 01:59:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76639, encodeId=b365e663922, content=愿技术不断完善, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Sun Apr 10 07:28:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76625, encodeId=9a82e66256c, content=可惜了,愿该项技术越来越成熟,惠及人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00531550470, createdName=layyjiangli, createdTime=Sat Apr 09 20:24:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76586, encodeId=093ce6586c4, content=随缘, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sat Apr 09 13:20:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76580, encodeId=7525e658051, content=看来3D打印器官时代快来了,永生梦想也开始起步了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sat Apr 09 12:30:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76578, encodeId=faa8e6578d4, content=子宫移植,还得抗排斥治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Sat Apr 09 12:11:00 CST 2016, time=2016-04-09, status=1, ipAttribution=)]
    2016-04-10 1de07360m07(暂无匿称)

    愿技术不断完善

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1645896, encodeId=90b41645896c2, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Thu Feb 23 22:59:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78134, encodeId=fdcee813456, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78135, encodeId=e829e813513, content=会好的会好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520304, encodeId=a1791520304c0, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Mon Apr 11 01:59:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76639, encodeId=b365e663922, content=愿技术不断完善, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Sun Apr 10 07:28:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76625, encodeId=9a82e66256c, content=可惜了,愿该项技术越来越成熟,惠及人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00531550470, createdName=layyjiangli, createdTime=Sat Apr 09 20:24:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76586, encodeId=093ce6586c4, content=随缘, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sat Apr 09 13:20:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76580, encodeId=7525e658051, content=看来3D打印器官时代快来了,永生梦想也开始起步了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sat Apr 09 12:30:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76578, encodeId=faa8e6578d4, content=子宫移植,还得抗排斥治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Sat Apr 09 12:11:00 CST 2016, time=2016-04-09, status=1, ipAttribution=)]
    2016-04-09 layyjiangli

    可惜了,愿该项技术越来越成熟,惠及人类

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1645896, encodeId=90b41645896c2, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Thu Feb 23 22:59:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78134, encodeId=fdcee813456, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78135, encodeId=e829e813513, content=会好的会好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520304, encodeId=a1791520304c0, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Mon Apr 11 01:59:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76639, encodeId=b365e663922, content=愿技术不断完善, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Sun Apr 10 07:28:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76625, encodeId=9a82e66256c, content=可惜了,愿该项技术越来越成熟,惠及人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00531550470, createdName=layyjiangli, createdTime=Sat Apr 09 20:24:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76586, encodeId=093ce6586c4, content=随缘, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sat Apr 09 13:20:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76580, encodeId=7525e658051, content=看来3D打印器官时代快来了,永生梦想也开始起步了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sat Apr 09 12:30:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76578, encodeId=faa8e6578d4, content=子宫移植,还得抗排斥治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Sat Apr 09 12:11:00 CST 2016, time=2016-04-09, status=1, ipAttribution=)]
    2016-04-09 1de3b290m83(暂无匿称)

    随缘

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1645896, encodeId=90b41645896c2, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Thu Feb 23 22:59:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78134, encodeId=fdcee813456, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78135, encodeId=e829e813513, content=会好的会好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520304, encodeId=a1791520304c0, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Mon Apr 11 01:59:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76639, encodeId=b365e663922, content=愿技术不断完善, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Sun Apr 10 07:28:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76625, encodeId=9a82e66256c, content=可惜了,愿该项技术越来越成熟,惠及人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00531550470, createdName=layyjiangli, createdTime=Sat Apr 09 20:24:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76586, encodeId=093ce6586c4, content=随缘, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sat Apr 09 13:20:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76580, encodeId=7525e658051, content=看来3D打印器官时代快来了,永生梦想也开始起步了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sat Apr 09 12:30:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76578, encodeId=faa8e6578d4, content=子宫移植,还得抗排斥治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Sat Apr 09 12:11:00 CST 2016, time=2016-04-09, status=1, ipAttribution=)]
    2016-04-09 lyh994

    看来3D打印器官时代快来了,永生梦想也开始起步了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1645896, encodeId=90b41645896c2, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Thu Feb 23 22:59:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78134, encodeId=fdcee813456, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78135, encodeId=e829e813513, content=会好的会好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:34:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520304, encodeId=a1791520304c0, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Mon Apr 11 01:59:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76639, encodeId=b365e663922, content=愿技术不断完善, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Sun Apr 10 07:28:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76625, encodeId=9a82e66256c, content=可惜了,愿该项技术越来越成熟,惠及人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00531550470, createdName=layyjiangli, createdTime=Sat Apr 09 20:24:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76586, encodeId=093ce6586c4, content=随缘, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sat Apr 09 13:20:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76580, encodeId=7525e658051, content=看来3D打印器官时代快来了,永生梦想也开始起步了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sat Apr 09 12:30:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76578, encodeId=faa8e6578d4, content=子宫移植,还得抗排斥治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Sat Apr 09 12:11:00 CST 2016, time=2016-04-09, status=1, ipAttribution=)]
    2016-04-09 Lisa971

    子宫移植,还得抗排斥治疗。

    0

相关资讯

卵子冷冻技术,圆女性妈妈之梦!

导语:长久以来,产科医生一直默默无闻的在边缘科室中工作,直到一组由瑞典产科医生组成的医疗团队成功实现了世界首例子宫移植并取得巨大成功后,公众才将产科的神秘大门推开,将曾经的忽视置之一旁。“子宫移植领域内的所有相关报道我都有所了解,它需要临床团队的医生们孜孜不倦、夜以继日的工作,才能将子宫成功异体移植,并成功娩下胎儿。”来自南加州大学凯克医学院妇产科助理教授Karine Chung博士如是说。迄今为

中国首例人子宫移植在西京医院成功实施

25日,大秦网从第四军医大学西京医院“成功实施全国首例子宫移植新闻发布会”上了解到:该院于11月20日成功将陕西安康一位母亲的子宫移入女儿体内。目前患者恢复良好,新移植子宫已经成活。作为国内首例子宫移植,该手术的成功实施,标志着我国在该领域取得突破性进展,为众多先天性无子宫,或后天因肿瘤、产后出血等而被迫切除子宫者带来了福音。女子意外查出无子宫 子宫移植是唯一希望接受移植的这名女子名叫杨华(化名)

男人5年内可以拥有子宫

男人有可能生孩子吗?上周克利夫兰临床医院的一项手术引发了针对这一问题的广泛讨论。这是一台子宫移植手术,患者是一名子宫功能丧失导致无法生育的女性。看到这则消息,我们心里可能都会猜想:既然子宫可以移植给女性,那是否也可以移植给男性呢? 答案是肯定的。理论上,男性可以接受子宫移植,并怀孕生育宝宝。然而,这一天这么快到来依然会令我们难以接受。 "我认为在未来5到10年之间,或许更快,男性子宫移植手

美国首例子宫移植术让女性重获生育力

据报道,美国俄亥俄州克利夫兰诊所有望将在接下来的几个月内完成美国首例子宫移植手术。手术的接受者是一些天生缺失子宫、因故切除子宫或子宫受损的女性,通过手术,她们将重获怀孕和生育的能力。但这只是暂时性移植,接受手术的女性在生下一两个孩子后,子宫就要被移除。 科技医学的发展,为治疗提高受孕率提供了新手段 先天性子宫缺失或后天子宫受损都有可能引发女性不孕不育,单纯医药调理不可能解决这种不孕症状。考

为女性同胞谋福利啦!子宫移植后孕育胎儿非难题

继英国医生为10位女性进行子宫移植手术的临床试验后,第一个通过子宫移植出生的英国婴儿有望在2017年出生。 去年,Medical News Today报道,世界上首例进行子宫移植的一位36岁的瑞典女士成功分娩。这位不愿意透露姓名的女士一出生便没有子宫,她的一位61岁的朋友把子宫捐献给她后,她生下了一个健康男婴,取名为Vincent。 如今,英国伦敦帝国理工学院的医生为10例没有子宫的英国女性进行了

美国完成国内首例子宫移植手术

据外媒报道,美国完成国内第一起子宫移植案例,替没有子宫的女性争取生育机会,这项手术将成为生殖医学的新前沿。医生把一名去世捐赠者的子宫,移植到一个26岁女性体内,手术历经9个小时。病患术后状况稳定,医院将等到下周召开记者会,再详细说明。在美国之前,已经有好几个国家,尝试过子宫移植,瑞典在2014年迎接第一个移植子宫孕育出来的新生儿,目前为止,已经有五个成功生产的案例。医生说,这项手术实际上还处于试验

Baidu
map
Baidu
map
Baidu
map